EMEA-001523-PIP04-19
Key facts
| Invented name |
Tremfya
|
| Active substance |
guselkumab
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/0461/2020
|
| PIP number |
EMEA-001523-PIP04-19
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of ulcerative colitis
|
| Route(s) of administration |
|
| Contact for public enquiries |
Janssen-Cilag International N.V.
Tel. +32 14602111 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|